US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by TELA Bio, Inc.

< Previous 1 2 3 Next >
News headline image
TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio Reports Second Quarter 2026 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director
From TELA Bio, Inc.
Via GlobeNewswire
Tickers BFLY TELA
News headline image
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio to Announce Second Quarter 2026 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio Reports First Quarter 2026 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
From TELA Bio, Inc.
Via GlobeNewswire
Tickers ANIK AXGN BVS ELUT MDXG TELA
News headline image
TELA Bio to Announce First Quarter 2026 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio to Announce Third Quarter 2025 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio Appoints William Plovanic to Board of Directors
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio Reports Second Quarter 2025 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio to Announce Second Quarter 2025 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio Appoints Jeffrey Blizard as President
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
News headline image
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
< Previous 1 2 3 Next >